Tenet Healthcare - THC Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
News Sentiment
About
FAQ

Consensus Rating: Buy
Consensus Price Target: $100.38
Forecasted Upside: 2.57%
Number of Analysts: 16
Breakdown:
0 Sell Ratings
1 Hold Ratings
14 Buy Ratings
1 Strong Buy Ratings

^$97.86 As of 04/23/2024 01:00 AM ET

▲ +3.01 (3.17%)

1 month | 3 months | 12 months

Get New Tenet Healthcare Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for THC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for THC

^$100.38

▲ +2.57% Upside Potential

This price target is based on 16 analysts offering 12 month price targets for Tenet Healthcare in the last 3 months. The average price target is $100.38, with a high forecast of $126.00 and a low forecast of $81.00. The average price target represents a 2.57% upside from the last price of $97.86.

Current Consensus is Buy

The current consensus among 16 investment analysts is to buy stock in Tenet Healthcare. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

1 strong buy ratings
14 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

10/31/2022

1 strong buy ratings
14 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

1/29/2023

1 strong buy ratings
14 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

4/29/2023

1 strong buy ratings
14 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

7/28/2023

1 strong buy ratings
14 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

10/26/2023

1 strong buy ratings
14 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

1/24/2024

1 strong buy ratings
14 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

3/24/2024

1 strong buy ratings
14 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

4/23/2024

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/12/2024	Deutsche Bank Aktiengesellschaft	Boost Target	Buy ➝ Buy	$100.00 ➝ $126.00	Low
4/10/2024	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Overweight	$104.00	Low
3/28/2024	Wells Fargo & Company	Boost Target	Overweight ➝ Overweight	$105.00 ➝ $115.00	N/A
3/27/2024	Wolfe Research	Upgrade	Peer Perform ➝ Outperform	$122.00	Low
3/6/2024	Barclays	Initiated Coverage	Overweight	$113.00	Low
3/5/2024	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Overweight	$104.00	Low
2/15/2024	Wells Fargo & Company	Boost Target	Overweight ➝ Overweight	$98.00 ➝ $105.00	Low
2/9/2024	Truist Financial	Boost Target	Buy ➝ Buy	$92.00 ➝ $105.00	Low
2/9/2024	Royal Bank of Canada	Boost Target	Outperform ➝ Outperform	$97.00 ➝ $109.00	Low
2/9/2024	Mizuho	Boost Target	Buy ➝ Buy	$90.00 ➝ $100.00	Low
2/9/2024	Cantor Fitzgerald	Boost Target	Overweight ➝ Overweight	$94.00 ➝ $104.00	Low
11/20/2023	Truist Financial	Reiterated Rating	Buy ➝ Buy	$92.00	Low
11/17/2023	JPMorgan Chase & Co.	Lower Target	Overweight ➝ Overweight	$91.00 ➝ $81.00	Low
11/14/2023	Jefferies Financial Group	Lower Target	Buy ➝ Buy	$95.00 ➝ $85.00	Low
11/9/2023	The Goldman Sachs Group	Lower Target	Buy ➝ Buy	$98.00 ➝ $85.00	Low
11/2/2023	UBS Group	Lower Target	Buy ➝ Buy	$104.00 ➝ $94.00	Low
11/1/2023	Raymond James	Lower Target	Strong-Buy ➝ Strong-Buy	$95.00 ➝ $90.00	Low
10/31/2023	Mizuho	Lower Target	Buy ➝ Buy	$94.00 ➝ $77.00	Low
10/31/2023	Royal Bank of Canada	Lower Target	Outperform ➝ Outperform	$87.00 ➝ $72.00	Low
10/20/2023	Wells Fargo & Company	Lower Target	Overweight ➝ Overweight	$83.00 ➝ $71.00	Low
9/14/2023	Cantor Fitzgerald	Boost Target	Overweight ➝ Overweight	$76.00 ➝ $94.00	Low
8/14/2023	The Goldman Sachs Group	Boost Target	Buy ➝ Buy	$89.00 ➝ $98.00	Low
8/2/2023	Raymond James	Boost Target	Strong-Buy ➝ Strong-Buy	$85.00 ➝ $95.00	Low
8/2/2023	Credit Suisse Group	Boost Target	Outperform ➝ Outperform	$92.00 ➝ $98.00	Low
8/1/2023	Royal Bank of Canada	Boost Target	Outperformer ➝ Outperform	$84.00 ➝ $87.00	Low
8/1/2023	UBS Group	Boost Target	Buy ➝ Buy	$95.00 ➝ $104.00	Low
8/1/2023	Stephens	Boost Target	Equal Weight ➝ Equal Weight	$87.00 ➝ $89.00	Low
8/1/2023	Citigroup	Boost Target	Buy ➝ Buy	$83.00 ➝ $90.00	Low
7/11/2023	Mizuho	Boost Target		$81.00 ➝ $94.00	Low
6/20/2023	Truist Financial	Boost Target		$84.00 ➝ $92.00	Low
5/16/2023	Mizuho	Boost Target		$78.00 ➝ $81.00	Low
4/26/2023	Deutsche Bank Aktiengesellschaft	Boost Target		$65.00 ➝ $81.00	Low
4/26/2023	Stephens	Boost Target		$64.00 ➝ $77.00	Low
4/26/2023	Truist Financial	Boost Target		$74.00 ➝ $84.00	Low
4/26/2023	Raymond James	Boost Target		$72.00 ➝ $85.00	Low
4/26/2023	Royal Bank of Canada	Boost Target		$73.00 ➝ $84.00	Low
4/26/2023	Barclays	Boost Target		$70.00 ➝ $105.00	Low
4/20/2023	Cantor Fitzgerald	Initiated Coverage	Overweight	$73.00	Low
4/19/2023	JPMorgan Chase & Co.	Initiated Coverage	Overweight	$72.00	Low
2/22/2023	Stephens	Boost Target	Equal Weight	$60.00 ➝ $64.00	N/A
2/17/2023	Wells Fargo & Company	Boost Target	Overweight	$59.00 ➝ $68.00	Low
2/17/2023	Mizuho	Boost Target	Buy	$60.00 ➝ $78.00	Low
2/14/2023	UBS Group	Boost Target	Buy	$47.00 ➝ $78.00	Low
2/14/2023	Barclays	Boost Target	Overweight	$67.00 ➝ $70.00	Low
2/10/2023	Deutsche Bank Aktiengesellschaft	Boost Target	Buy	$48.00 ➝ $65.00	Low
2/10/2023	Truist Financial	Boost Target	Buy	$60.00 ➝ $66.00	Low
2/10/2023	Royal Bank of Canada	Boost Target	Outperform	$69.00 ➝ $73.00	Low
2/10/2023	Mizuho	Reiterated Rating	Buy	$60.00	Low
2/10/2023	Stephens	Boost Target	Equal Weight	$57.00 ➝ $60.00	Low
1/3/2023	Wells Fargo & Company	Boost Target	Overweight	$48.00 ➝ $59.00	Low
1/3/2023	Truist Financial	Boost Target		$55.00 ➝ $60.00	Low
12/6/2022	Loop Capital	Boost Target		$40.00 ➝ $45.00	Low
11/2/2022	Mizuho	Lower Target	Buy	$80.00 ➝ $60.00	Low
11/1/2022	The Goldman Sachs Group	Lower Target	Buy	$93.00 ➝ $80.00	Low
10/27/2022	Credit Suisse Group	Lower Target		$80.00	Low
10/27/2022	Raymond James	Lower Target	Strong-Buy	$135.00 ➝ $80.00	Low
10/25/2022	Citigroup	Lower Target	Buy	$99.00 ➝ $76.00	Low
10/25/2022	SVB Leerink	Lower Target	Outperform	$89.00 ➝ $55.00	Low
10/24/2022	Stephens	Lower Target	Equal Weight	$65.00 ➝ $45.00	Low
10/24/2022	Truist Financial	Lower Target		$80.00 ➝ $55.00	Low
10/24/2022	Deutsche Bank Aktiengesellschaft	Lower Target	Buy	$90.00 ➝ $48.00	Low
10/24/2022	Wells Fargo & Company	Lower Target	Overweight	$82.00 ➝ $48.00	Low
10/24/2022	Barclays	Lower Target	Overweight	$104.00 ➝ $67.00	Low
10/21/2022	Bank of America	Lower Target		$79.00 ➝ $64.00	Low
8/24/2022	SVB Leerink	Boost Target	Outperform	$88.00 ➝ $93.00	Low
8/2/2022	Mizuho	Boost Target	Buy	$63.00 ➝ $80.00	Low
7/29/2022	Wells Fargo & Company	Lower Target		$90.00 ➝ $82.00	Low
7/28/2022	UBS Group	Lower Target	Buy	$113.00 ➝ $91.00	Low
7/25/2022	Stephens	Boost Target		$73.00	Low
7/25/2022	Truist Financial	Boost Target	Buy	$75.00 ➝ $80.00	Low
7/25/2022	SVB Leerink	Boost Target	Outperform	$68.00 ➝ $88.00	Low
7/25/2022	Citigroup	Lower Target	Buy	$110.00 ➝ $99.00	Low
7/24/2022	Bank of America	Boost Target		$70.00 ➝ $75.00	Low
7/19/2022	Credit Suisse Group	Set Target		$104.00	Low
7/15/2022	SVB Leerink	Lower Target	Outperform	$110.00 ➝ $68.00	Low
7/12/2022	The Goldman Sachs Group	Lower Target	Buy	$108.00 ➝ $93.00	N/A
7/11/2022	Raymond James	Lower Target	Strong-Buy	$120.00 ➝ $110.00	N/A
7/7/2022	Deutsche Bank Aktiengesellschaft	Lower Target	Buy	$110.00 ➝ $90.00	N/A
7/1/2022	Mizuho	Lower Target	Buy	$103.00 ➝ $63.00	Low
6/16/2022	Loop Capital	Initiated Coverage	Buy	$80.00	Low
4/25/2022	Wells Fargo & Company	Lower Target	Overweight	$100.00 ➝ $90.00	High
4/22/2022	SVB Leerink	Boost Target	Outperform	$100.00 ➝ $110.00	High
4/22/2022	Royal Bank of Canada	Boost Target	Outperform	$89.00 ➝ $104.00	High
4/22/2022	Deutsche Bank Aktiengesellschaft	Boost Target	Buy	$100.00 ➝ $110.00	High
4/22/2022	Citigroup	Boost Target	Buy	$96.00 ➝ $110.00	High
4/22/2022	Barclays	Boost Target	Overweight	$99.00 ➝ $104.00	High
4/14/2022	SVB Leerink	Reiterated Rating	Buy	$100.00	N/A
4/7/2022	Truist Financial	Boost Target		$90.00 ➝ $100.00	Low
3/28/2022	Wells Fargo & Company	Initiated Coverage	Overweight	$100.00	Medium
3/7/2022	Jefferies Financial Group	Boost Target	Buy	$120.00 ➝ $125.00	Low
3/3/2022	Mizuho	Boost Target	Buy	$90.00 ➝ $103.00	Medium
3/1/2022	The Goldman Sachs Group	Reiterated Rating	Buy ➝ Buy		High
2/10/2022	UBS Group	Upgrade	Neutral ➝ Buy	$83.00 ➝ $111.00	High
2/9/2022	Credit Suisse Group	Boost Target	Outperform	$109.00 ➝ $111.00	High
2/9/2022	Deutsche Bank Aktiengesellschaft	Boost Target	Buy	$80.00 ➝ $100.00	High
2/9/2022	SVB Leerink	Upgrade	Market Perform ➝ Outperform	$88.00 ➝ $100.00	High
2/9/2022	Barclays	Boost Target	Overweight	$87.00 ➝ $99.00	High
2/9/2022	Truist Financial	Upgrade	Hold ➝ Buy	$90.00	High
1/20/2022	Raymond James	Upgrade	Outperform ➝ Strong-Buy	$105.00 ➝ $120.00	Medium
1/7/2022	SVB Leerink	Boost Target	Market Perform	$78.00 ➝ $88.00	Medium
1/5/2022	Truist Financial	Boost Target		$78.00 ➝ $90.00	High
12/21/2021	Barclays	Boost Target	Overweight	$81.00 ➝ $87.00	High
11/10/2021	Mizuho	Boost Target	Buy	$75.00 ➝ $90.00	Low
11/9/2021	Stephens	Boost Target	Equal Weight	$77.00 ➝ $92.00	Low
10/25/2021	Citigroup	Boost Target	Buy	$88.00 ➝ $91.00	Low
10/22/2021	SVB Leerink	Lower Target	Market Perform	$80.00 ➝ $78.00	Medium
10/22/2021	Truist Financial	Boost Target	Hold	$72.00 ➝ $78.00	Low
10/22/2021	Credit Suisse Group	Boost Target	Outperform	$88.00 ➝ $95.00	Low
10/13/2021	Truist Financial	Lower Target	Hold	$78.00 ➝ $72.00	Low
9/27/2021	SVB Leerink	Initiated Coverage	Market Perform	$80.00	High
9/23/2021	UBS Group	Initiated Coverage	Neutral	$83.00	Medium
9/8/2021	Barclays	Boost Target	Overweight	$78.00 ➝ $79.00	Low
8/12/2021	Barclays	Upgrade	Equal Weight ➝ Overweight	$62.00 ➝ $77.00	Medium
8/9/2021	Mizuho	Boost Target	Buy	$70.00 ➝ $75.00	Low
7/23/2021	Credit Suisse Group	Boost Target	Outperform	$71.00 ➝ $88.00	Medium
7/23/2021	Citigroup	Initiated Coverage	Buy	$70.84	Medium
7/23/2021	Royal Bank of Canada	Boost Target	Outperform	$78.00 ➝ $83.00	Medium
7/23/2021	Deutsche Bank Aktiengesellschaft	Boost Target	Buy	$69.00 ➝ $80.00	Medium
7/9/2021	Seaport Res Ptn	Reiterated Rating	Buy		Medium
6/18/2021	Jefferies Financial Group	Reiterated Rating	Buy		High
5/5/2021	Mizuho	Boost Target	Buy	$55.00 ➝ $70.00	Low
5/3/2021	The Goldman Sachs Group	Initiated Coverage	Buy		High
4/23/2021	Barclays	Boost Target		$55.00 ➝ $62.00	High
4/22/2021	Truist Financial	Boost Target		$56.00 ➝ $60.00	Medium
4/22/2021	Citigroup	Boost Target		$58.00 ➝ $65.00	High
4/22/2021	Credit Suisse Group	Boost Target	Outperform	$58.00 ➝ $71.00	High
4/22/2021	Royal Bank of Canada	Boost Target	Outperform	$57.00 ➝ $66.00	High
4/9/2021	Mizuho	Boost Target	Buy	$48.00 ➝ $55.00	Medium
2/11/2021	Citigroup	Boost Target		$50.00 ➝ $58.00	Low
2/11/2021	Credit Suisse Group	Boost Target	Outperform	$52.00 ➝ $58.00	Low
1/21/2021	UBS Group	Boost Target	Positive ➝ Buy	$37.00 ➝ $60.00	High
1/14/2021	Raymond James	Boost Target	Outperform	$55.00 ➝ $60.00	High
1/8/2021	Jefferies Financial Group	Upgrade	Hold ➝ Buy	$27.00 ➝ $60.00	Low
1/5/2021	Bank of America	Upgrade	Neutral ➝ Buy	$45.00 ➝ $50.00	N/A
12/18/2020	Mizuho	Boost Target	Buy	$32.00 ➝ $48.00	Medium
12/15/2020	Deutsche Bank Aktiengesellschaft	Upgrade	Hold ➝ Buy		Medium
12/11/2020	Smith Barney Citigroup	Boost Target		$33.00 ➝ $50.00	High
12/11/2020	Credit Suisse Group	Boost Target	Outperform	$39.00 ➝ $48.00	Medium
12/11/2020	Barclays	Boost Target	Equal Weight	$28.00 ➝ $46.00	High
11/11/2020	Piper Sandler	Boost Target	Neutral	$31.00 ➝ $36.00	High
11/9/2020	Mizuho	Boost Target	Buy	$30.00 ➝ $32.00	High
10/22/2020	Raymond James	Boost Target	Outperform	$40.00 ➝ $43.00	High
9/21/2020	JPMorgan Chase & Co.	Downgrade	Neutral ➝ Underweight	$28.00 ➝ $20.00	High
9/4/2020	Royal Bank of Canada	Boost Target		$30.00 ➝ $35.00	Low
8/14/2020	Truist Financial	Boost Target		$21.00 ➝ $30.00	Medium
8/10/2020	UBS Group	Boost Target	Buy	$30.00 ➝ $35.00	Low
8/5/2020	Deutsche Bank Aktiengesellschaft	Boost Target	Hold	$25.00 ➝ $28.00	High
8/4/2020	Credit Suisse Group	Reiterated Rating	Buy		High
6/11/2020	UBS Group	Lower Target	Buy	$32.00 ➝ $30.00	High
5/29/2020	Mizuho	Lower Target	Buy	$32.00 ➝ $30.00	High
5/21/2020	SunTrust Banks	Boost Target	Hold	$22.00 ➝ $25.00	Medium
5/20/2020	Citigroup	Lower Target	Buy	$35.00 ➝ $27.00	High
5/14/2020	UBS Group	Lower Target	Buy	$49.00 ➝ $32.00	High
5/11/2020	Barclays	Boost Target	Equal Weight	$19.00 ➝ $22.00	Low
5/6/2020	Credit Suisse Group	Reiterated Rating	Buy	$33.00	Low
5/6/2020	Wells Fargo & Company	Lower Target	Equal Weight	$40.00 ➝ $32.00	Low
5/6/2020	Deutsche Bank Aktiengesellschaft	Lower Target	Hold	$31.00 ➝ $25.00	High
4/13/2020	SunTrust Banks	Boost Target	Hold	$18.00 ➝ $22.00	Low
4/13/2020	Royal Bank of Canada	Reiterated Rating	Buy	$26.00	Medium
4/3/2020	SunTrust Banks	Lower Target	Hold	$42.00 ➝ $18.00	High
3/25/2020	Barclays	Reiterated Rating	Hold	$19.00	High
3/11/2020	Royal Bank of Canada	Upgrade	Sector Perform ➝ Outperform	$32.00 ➝ $39.00	High
2/26/2020	JPMorgan Chase & Co.	Upgrade	Underweight ➝ Neutral	$31.00 ➝ $32.00	High
1/3/2020	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Hold	$20.00	Low
12/20/2019	JPMorgan Chase & Co.	Boost Target	Underweight	$23.00 ➝ $31.00	Medium
12/18/2019	SunTrust Banks	Boost Target	Hold	$31.00 ➝ $42.00	Medium
12/9/2019	UBS Group	Upgrade	Neutral ➝ Buy	$24.00 ➝ $53.00	High
11/7/2019	Mizuho	Reiterated Rating	Buy		Low
11/6/2019	Mizuho	Boost Target		$30.00 ➝ $33.00	Low
11/6/2019	SunTrust Banks	Boost Target	Hold	$24.00 ➝ $31.00	High
11/6/2019	Credit Suisse Group	Upgrade	Neutral ➝ Outperform	$25.00 ➝ $36.00	High
8/14/2019	The Goldman Sachs Group	Initiated Coverage	Neutral ➝ Neutral	$28.00 ➝ $28.00	High
8/11/2019	Royal Bank of Canada	Reiterated Rating	Hold	$26.00	Medium
8/7/2019	SunTrust Banks	Set Target	Hold	$24.00	Low
5/1/2019	SunTrust Banks	Lower Target	Hold	$27.00	High

(Data available from 4/24/2019 forward)

News Sentiment Rating

0.78 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

15 very positive mentions
5 positive mentions
2 negative mentions
0 very negative mentions

Mentions as of

9/26/2023

10 very positive mentions
8 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

10/26/2023

3 very positive mentions
21 positive mentions
2 negative mentions
0 very negative mentions

Mentions as of

11/25/2023

12 very positive mentions
5 positive mentions
1 negative mentions
0 very negative mentions

Mentions as of

12/25/2023

11 very positive mentions
4 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

1/24/2024

33 very positive mentions
23 positive mentions
1 negative mentions
0 very negative mentions

Mentions as of

2/23/2024

23 very positive mentions
18 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

3/24/2024

12 very positive mentions
18 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

4/23/2024

Current Sentiment

Recent Stories by Sentiment

Very Negative

No very negative mentions tracked during this time.

Negative

No negative mentions tracked during this time.

Positive

americanbankingnews.com
4/23/2024
Tenet Healthcare (THC) Set to Announce Quarterly Earnings on Tuesday
forbes.com
4/22/2024
Pipe’s Big Small Business Pivot: Embedded Finance For SMBs
americanbankingnews.com
4/20/2024
Tenet Healthcare (NYSE:THC) Stock Price Down 5.7%
reuters.com
4/19/2024
Tenet Healthcare, union coalition reach tentative deal
finance.yahoo.com
4/18/2024
Tenet Healthcare Corporation (THC)

Very Positive

marketbeat.com
4 hours ago
Mirae Asset Global Investments Co. Ltd. Invests $946,000 in Tenet Healthcare Co. (NYSE:THC)
msn.com
4/22/2024
Tenet reaches tentative agreement with workers union
marketbeat.com
4/21/2024
Tenet Healthcare Co. (NYSE:THC) Shares Purchased by Allspring Global Investments Holdings LLC
marketbeat.com
4/19/2024
Kestrel Investment Management Corp Reduces Stake in Tenet Healthcare Co. (NYSE:THC)
finance.yahoo.com
4/19/2024
UPDATE 1-Tenet Healthcare, union coalition reach tentative deal

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; tertiary care services, such as cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; quaternary care services in heart and kidney transplants; and limb salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging, surgical robotic, and telemedicine access services. In addition, it offers a range of procedures and services, such as orthopedics, total joint replacement, and spinal and other musculoskeletal procedures; gastroenterology; pain management; otolaryngology; ophthalmology; and urology. It operates hospitals, ambulatory surgery centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.

Today's Range

Now: $97.86

$95.71

$98.41

50 Day Range

MA: $97.75

$87.94

$105.11

52 Week Range

Now: $97.86

$51.04

$107.80

Volume

1,276,757 shs

Average Volume

941,509 shs

Market Capitalization

$9.71 billion

P/E Ratio

17.14

Dividend Yield

N/A

Beta

2.08

Frequently Asked Questions

What sell-side analysts currently cover shares of Tenet Healthcare?: The following Wall Street research analysts have issued stock ratings on Tenet Healthcare in the last year: Barclays PLC, Cantor Fitzgerald, Citigroup Inc., Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Jefferies Financial Group Inc., JPMorgan Chase & Co., Mizuho, Raymond James, Royal Bank of Canada, Stephens, StockNews.com, The Goldman Sachs Group, Inc., TheStreet, Truist Financial Co., UBS Group AG, Wells Fargo & Company, and Wolfe Research.
View the latest analyst ratings for THC.
What is the current price target for Tenet Healthcare?: 16 Wall Street analysts have set twelve-month price targets for Tenet Healthcare in the last year. Their average twelve-month price target is $100.38, suggesting a possible upside of 2.6%. Deutsche Bank Aktiengesellschaft has the highest price target set, predicting THC will reach $126.00 in the next twelve months. JPMorgan Chase & Co. has the lowest price target set, forecasting a price of $81.00 for Tenet Healthcare in the next year.
View the latest price targets for THC.
What is the current consensus analyst rating for Tenet Healthcare?: Tenet Healthcare currently has 1 hold rating, 14 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe THC will outperform the market and that investors should add to their positions of Tenet Healthcare.
View the latest ratings for THC.
What other companies compete with Tenet Healthcare?: Other companies that are similar to Tenet Healthcare include Universal Health Services, Surgery Partners, Teleflex, Bio-Rad Laboratories and Bio-Techne. Learn More about companies similar to Tenet Healthcare.
How do I contact Tenet Healthcare's investor relations team?: Tenet Healthcare's physical mailing address is 14201 Dallas Parkway, DALLAS TX, 75254. The company's listed phone number is (469) 893-2200 and its investor relations email address is [email protected]. The official website for Tenet Healthcare is www.tenethealth.com. Learn More about contacing Tenet Healthcare investor relations.

Tenet Healthcare - THC Stock Price Target and Predictions

Analyst Price Target for THC

Current Consensus is Buy

Past Monthly Recommendations

Latest Recommendations

News Sentiment Rating

0.78 (Buy)

News Sentiment Over Time

Current Sentiment

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of Tenet Healthcare?

What is the current price target for Tenet Healthcare?

What is the current consensus analyst rating for Tenet Healthcare?

What other companies compete with Tenet Healthcare?

How do I contact Tenet Healthcare's investor relations team?